Chemotherapy for Breast Cancer

Follow the links below to find information on chemotherapy for breast cancer.

Reviewed September 2011

Printer friendly page Printer friendly page

Related HealthInsite Topics

Systematic Reviews of Chemotherapy for Breast Cancer

HealthInsite Topic Page
Links to systematic reviews of the evidence for the effectiveness of chemotherapy for breast cancer.

14 Resources Found

Results 1 to 14 displayed.

Title:   Late stage metastatic breast cancer
Publisher:   Medicare Australia
Description:   The Australian Government funds a program to make sure Herceptin is available free of charge for late stage metastatic breast cancer.
Date:   Sep 2011
Title:   Breast cancer
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   Women who develop breast cancer may be at risk of osteoporosis.
Date:   Jul 2011
Title:   Recommendations for Aromatase inhibitors as adjuvant endocrine therapy
Publisher:   Cancer Australia
Description:   To provide statements and recommendations, based on the best available evidence, about the use of aromatase inhibitors as adjuvant endocrine therapy for post-menopausal women with hormone receptor-positive early invasive breast cancer.
Date:   Jul 2006
Title:   Recommendations for use of Trastuzumab (Herceptin& #174; )
Publisher:   Cancer Australia
Description:   To provide statements and recommendations based on the best available evidence, about the use of trastuzumab (Herceptin) as adjuvant therapy for the treatment of patients with HER2-positive early breast cancer and for the treatment of patients with HER2-positive metastatic breast cancer.
Date:   May 2007
Title:   Recommendations for use of Bisphosphonates
Publisher:   National Breast and Ovarian Cancer Centre (NBOCC)
Description:   This guideline includes statements and recommendations based on available, high-level evidence about the use of bisphosphonates for advanced breast cancer. The guideline provides health professionals
Date:   Jun 2011
Title:   Recommendations for use of Chemotherapy
Publisher:   Cancer Australia
Description:   This guideline includes statements and recommendations based on available, high-level evidence about the use of chemotherapy for the treatment of advanced breast cancer. The guideline provides health
Date:   Jul 2010
Title:   Chemotherapy
Publisher:   Cancer Australia
Description:   Chemotherapy for early breast cancer uses drugs to destroy any cancer cells that may have spread outside the breast and armpit area to other parts of the body or are left in the breast and armpit area but cannot be detected.
Date:   Jul 2009
Title:   Side effects of chemotherapy
Publisher:   Cancer Australia
Description:   Because the drugs all work differently, they have different side effects. Chemotherapy drugs can also affect individual women in different ways. Most side effects of chemotherapy can be managed with medical care. Side effects can include nausea, vomiting, fatigue, tiredness, hair loss, diarrhoea, constipation, weight gain, weight loss, depression, anxiety, menopausal symptoms, sexual difficulties, mouth ulcers and infections, skin changes, nail changes, nerve, muscle problems, swelling, feeling vague, in a fog, infection, bleeding, bruising, kidney problems, bladder problems, heart problems, bone marrow problems, allergic reactions.
Date:   Jul 2009
Title:   What does chemotherapy involve?
Publisher:   Cancer Australia
Description:   Before starting chemotherapy treatment, the woman will meet with a medical oncologist to discuss which types of chemotherapy are recommended and the side effects of these treatments.
Date:   Jul 2009
Title:   Recommedations for use of Taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer
Publisher:   Cancer Australia
Description:   A clinical practice guideline developed by NBOCC. This document supplements systemic adjuvant therapy guideline recommendations 12-22 (pp 8-10), specially those about chemotherapy regimens contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001
Date:   Aug 2001
Title:   PBAC: taxanes
Publisher:   Australian Prescriber
Description:   The listing of trastuzumab on the Pharmaceutical Benefits Scheme (PBS) in October 2006 was heralded with much fanfare. Along with this listing, changes to the prescribing requirements for taxanes also occurred.
Date:   Feb 2007
Title:   Listing of Herceptin on the PBS
Publisher:   Australian Government Department of Health and Ageing
Description:   The Government has accepted a recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC) to list the drug trastuzumab (Herceptin®) on the Pharmaceutical Benefits Scheme (PBS).
Date:   Oct 2006
Title:   Cancer antibodies (Comment for consumers)
Publisher:   Australian Prescriber
Description:   To reduce side effects, new treatments are needed which will kill the cancer cells but not damage normal cells. One approach is to make antibodies against the cancer cells.
Date:   Dec 2003
Title:   Antineoplastic antibodies - clinical applications
Publisher:   Australian Prescriber
Description:   Trastuzumab and rituximab are genetically engineered antibodies which are now available for the treatment of metastatic breast cancer and non-Hodgkin's lymphoma respectively.
Date:   Dec 2003

Results 1 to 14 displayed.